84066 Assay prostate phosphatase
Also known as: prostate-specific acid phosphatase, PAP test
Quantitative measurement of prostate-specific acid phosphatase in serum using immunoassay methodology.
In Plain Language
prostate cancer marker; prostate enzyme
Clinical Context
Assessment of prostate cancer burden and metastatic disease. Historically important; now largely replaced by prostate-specific antigen (PSA) which is more sensitive and specific.
RVU Information
CPT 84066 does not have a physician work RVU assigned by CMS. Reimbursement for this code is determined by payer-specific fee schedules.
Billing & Documentation
Lab and pathology codes require an order from the treating provider with clinical indication. For molecular pathology and genetic testing, document the specific analytes tested and clinical rationale.
How This Code Compares
This code has a work RVU of 0.00, meaning it does not have a physician work component assigned by CMS. In the Pathology & Lab category, 94% of codes share this characteristic.
Specialties
Frequently Asked Questions
What is CPT code 84066?
CPT 84066 (Assay prostate phosphatase) is a Pathology & Lab code. Quantitative measurement of prostate-specific acid phosphatase in serum using immunoassay methodology.
Who uses CPT code 84066?
CPT 84066 is used by Pathology, Urology, Oncology. Assessment of prostate cancer burden and metastatic disease. Historically important; now largely replaced by prostate-specific antigen (PSA) which is more sensitive and specific.
When is CPT 84066 used?
Assessment of prostate cancer burden and metastatic disease. Historically important; now largely replaced by prostate-specific antigen (PSA) which is more sensitive and specific.
Track This Code in RVU Edge
Log procedures, calculate wRVUs, and benchmark against national data — all in one app.
CPT® is a registered trademark of the American Medical Association. Data sourced from CMS Physician Fee Schedule RVU26A. Descriptions, synonyms, and clinical context are original content by RVU Edge.